WHO ICTRP trial
Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults
RPCEC00000030 · Registro Público Cubano de Ensayos Clínicos (RPCEC) · Not Recruiting
Key facts
| Trial ID | RPCEC00000030 |
|---|---|
| Public title | Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults |
| Scientific title | Clinical trial of Dermatophagoides siboney (VALERGEN-DS) allergenic extract for sublingual therapeutic use in asthmatic adults sensitive to this allergen |
| Primary sponsor | National Biopreparations Center (BIOCEN) |
| Secondary sponsors | Not applicable |
| Registry | Registro Público Cubano de Ensayos Clínicos (RPCEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Cuba |
| Conditions | Bronchial asthma.;Asthma;Bronchial Diseases;Lung Diseases, Obstructive;Lung Diseases;Respiratory Tract Diseases;Respiratory Hypersensitivity;Hypersensitivity, Immediate;Hypersensitivity; Immune System Diseases;Environmental Illness |
| Interventions | Active) study group: The study group was given increasing sublingual volumes (drops) of the researched vaccine at different doses (20, 200 and 2,000 BU/ml) for three weeks during the incremental phase. Afterwards, during the maintenance… |
| Registration date | Aug 12, 2010 |
| Target size | 40 patients (20 active, 20 placebo) |
| Secondary IDs | 2005CALIXTOSL-DS05 |
| Registry page | rpcec.sld.cu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: